BMC Medical Co

BMC Medical Co Gross Margin

The Gross Margin of BMC Medical Co (301367.SZ) as of Nov 4, 2026 is 52.93 %. In the previous year, Gross Margin was 48.34 % — a change of 9.50% (higher).

Gross Margin

52.93 %

YoY

9.50%

Last updated:

Gross Margin of BMC Medical Co is 2025 52.93 % . Gross Margin of BMC Medical Co was 2024 48.34 % . It decreases by 9.50% higher compared to the previous year.

BMC Medical Co's gross margin stands at 52.9%, up from 43.2% several years earlier.

The BMC Medical Co Gross Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Gross Margin
Date
Gross Margin
Jan 1, 2019
48.81 CNY
Jan 1, 2020
100.00 CNY
Jan 1, 2021
43.24 CNY
Jan 1, 2022
41.63 CNY
Jan 1, 2023
45.94 CNY
Jan 1, 2024
48.34 CNY
Jan 1, 2025
52.93 CNY
The BMC Medical Co Gross Margin history
YEARGross MarginYoY
52.93 %+9.50%
48.34 %+5.22%
45.94 %+10.35%
41.63 %-3.72%
43.24 %-56.76%
100.00 %+104.86%
48.81 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

BMC Medical Co Stock analysis

What does BMC Medical Co do? BMC Medical Co. Ltd. generates revenue through the research, development, production, and sale of medical equipment and consumable products focused on respiratory health. The company offers non-invasive home ventilators, ventilation masks, sleep monitors, and high-flow humidified oxygen therapy devices. Its primary customers are patients with sleep apnea-hypopnea syndrome (SAHS), particularly obstructive sleep apnea syndrome (OSA), and patients with respiratory insufficiency, mainly chronic obstructive pulmonary disease (COPD). The firm provides chronic disease management services as part of its full-cycle treatment solutions. The company's product portfolio includes non-invasive home ventilators, ventilation masks, sleep monitors, and high-flow humidified oxygen therapy devices, all designed for respiratory health applications. These products target patients suffering from OSA and COPD, addressing both acute and chronic respiratory conditions. BMC Medical Co. Ltd. focuses on delivering comprehensive treatment services through a multi-scenario approach for these specific patient segments. Revenue streams are derived from the sale of medical equipment and consumables, as well as chronic disease management services. The company's services are tailored for patients with SAHS and COPD, providing integrated solutions across the treatment cycle. This includes both the physical products and the ongoing management support for long-term respiratory health needs. BMC Medical Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about BMC Medical Co stock

Gross Margin of BMC Medical Co is 52.93 % in 2025.

Gross Margin of BMC Medical Co changed from 48.34 % to 52.93 %, representing a 9.50% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Gross Margin BMC Medical Co since 2006 – with annual values, charts, and detailed analysis.

Gross Margin measures the percentage of revenue remaining after COGS. Higher gross margins indicate more efficient production and stronger pricing power.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Gross Margin's BMC Medical Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Gross Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Gross Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — BMC Medical Co

All Key Metrics — BMC Medical Co